Regardless of whether you are using our products or not, the team at AQNZ are interested in your operation. AQNZ routinely reviews various aquaculture practices and research protocols, providing valuable insight into fish physiology and stress. AQNZ has a library full of data generated from industry relevant studies. Please trawl our website or contact us with any questions you have on fish stress, aquatic anaesthetics or any other related questions you have. Please also register to the website to gain access to additional resources, including a video library, efficacy graphs and technical notes.
AQUI-S® is an aquatic anaesthetic that has been developed to give flexibility and control in animal husbandry, transporting and harvesting operations. The ingredients are approved for use in foods and AQUI-S® is safe for use in food fish. Fish that are harvested using AQUI-S® have improved flesh quality, greater yield and longer shelf lives. The use of AQUI-S® during the transportation of live fish and during health management practices lowers stress and reduces mortalities.
November 2018
We are excited to announce the appointment of Veterquimica S.A. as the new distributor for AQUI-S products in Chile. Veterquimica S.A. has more than 45 years experience in the market and has business branches in Animal Health, Animal Nutrition, Hygiene and Biosecurity, and Service Laboratory. Within the aquaculture segment, Veterquimica S.A. is actively developing and selling products for fish health, fish nutrition and farm biosecurity/hygiene. This makes Veterquimica S.A. an ideal partner for our AQUI-S aquatic sedative.
Bathing salmon in fresh water is a commercially important tool for the control of various diseases including Sea Lice and Amoebic gill disease (AGD). These treatment operations are well known to be stressful to the fish which in turn causes significant quality issues during and post-treatment. A recent study conducted in Norway has further hilighted exactly how stressful these proceedures are in terms of cortisol release. If you would like more information from this study or other related work, please contact AQUI-S New Zealand directly (CLICK HERE)
Disease treatments in aquaculture have become a frequent and essential part of production. In the salmon industry the frequency of treatments has increased whilst the effectiveness, in most cases, has reduced. This is leading to higher costs associated with the practice and higher mortalities.
Over the last 12 months AQUI-S New Zealand Ltd (AQNZ), together with its distributor in Norway, ScanVacc, have been working closely with customers to investigate the benefit of AQUI-S® sedation during conventional Sea Lice and AGD treatments in cages and well boats. Based on customer feedback AQUI-S® sedation is giving greater safety margins, improved water quality and reduced mortality.
CAGEtreatment protocol |
WELL BOATtreatment protocol |
![]() |
![]() |
It is with great pleasure to inform you that AQUI-S New Zealand Ltd. has appointed Syndel Asia as the distributor for AQUI-S products in the territories of Malaysia and Singapore. Syndel Asia is perfectly positioned to distribute AQUI-S Products and has vast experience in Asian aquaculture and aquatic anaesthetics. Having product in Malaysia will significantly cut down delivery times to local markets and remove any import challenges associated with each shipment. I would encourage you to contact AQUI-S New Zealand or Syndel Asia if you have any questions or if you would like to place an order.
| PO Box 44-269 Lower Hutt, New Zealand PHONE: +64 4 587 0389 FAX: +64 4 587 0388 E.MAIL: This email address is being protected from spambots. You need JavaScript enabled to view it. |
Looking for more information? Contact our helpful team today for the perfect solution for your particular needs. |
![]() |